News

We solve complex problems with our sponsor partners in order to advance new medicines and therapies targeting all of mental health – CNS, pain, psychiatry, psychedelics, addiction, etc. Check out our latest news and see where we are making a difference.

Filters

Content Types

News
woman in front of multiple monitors

PRESS RELEASE – Cognitive Research Corporation Names C. Gordon “Chip” Gillooly as New CEO

Cognitive Research Corporation (CRC), a leading neuroscience clinical services company, announced that C. Gordon “Chip” Gillooly has been named Chief Executive Officer. Mr. Gillooly succeeds Dr. Tom Hochadel, Co-Founder, who will now serve as President and will continue to play an integral role in the company’s growth and delivery of exceptional CRO services to our clients. Dr. Gary Kay, Co-Founder and Head of Psychometric Assessments, will remain Chief Science Officer. CRC has been supporting clinical development for CNS-focused small to mid-size pharma, biotech, and medical device companies for over 16 years. The company has experienced explosive growth over the past five years as the CNS market has accelerated.

Read More
digitized brain with network of neurons

Evaluating Drug Effects on the Ability to Operate a Motor Vehicle

The purpose of this guidance is to assist pharmaceutical sponsors in the evaluation of the effects of psychoactive drugs on the ability to operate a motor vehicle. Specifically, this guidance addresses the FDA’s current thinking regarding the FDA-regulated drugs for which such evaluation may be needed, and the types of studies that such an evaluation entails.

Read More